Artificial intelligence in digital pathology: a roadmap to routine use in clinical practice

The use of artificial intelligence will transform clinical practice over the next decade and the early impact of this will likely be the integration of image analysis and machine learning into routine histopathology. In the UK and around the world, a digital revolution is transforming the reporting practice of diagnostic histopathology and this has sparked a proliferation of image analysis software tools. While this is an exciting development that could discover novel predictive clinical information and potentially address international pathology workforce shortages, there is a clear need for a robust and evidence‐based framework in which to develop these new tools in a collaborative manner that meets regulatory approval. With these issues in mind, the NCRI Cellular Molecular Pathology (CM‐Path) initiative and the British In Vitro Diagnostics Association (BIVDA) have set out a roadmap to help academia, industry, and clinicians develop new software tools to the point of approved clinical use. © 2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

[1]  Karl Broich,et al.  The new EU regulation on in vitro diagnostics: potential issues at the interface of medicines and companion diagnostics. , 2016, Biomarkers in medicine.

[2]  Marcial García-Rojo,et al.  New European Union Regulations Related to Whole Slide Image Scanners and Image Analysis Software , 2019, Journal of pathology informatics.

[3]  Karin Oien,et al.  Quality assurance guidance for scoring and reporting for pathologists and laboratories undertaking clinical trial work , 2018, The journal of pathology. Clinical research.

[4]  David B. A. Epstein,et al.  Novel digital signatures of tissue phenotypes for predicting distant metastasis in colorectal cancer , 2018, Scientific Reports.

[5]  Liron Pantanowitz,et al.  Current State of the Regulatory Trajectory for Whole Slide Imaging Devices in the USA , 2017, Journal of pathology informatics.

[6]  Yee-Wah Tsang,et al.  Validation of digital pathology imaging for primary histopathological diagnosis , 2016, Histopathology.

[7]  Mario Plebani,et al.  Regulation of in vitro diagnostics (IVDs) for use in clinical diagnostic laboratories: towards the light or dark in clinical laboratory testing? , 2011, Clinical chemistry and laboratory medicine.

[8]  Daisuke Komura,et al.  Machine Learning Methods for Histopathological Image Analysis , 2017, Computational and structural biotechnology journal.

[9]  Andrew Wallace,et al.  A standardized framework for the validation and verification of clinical molecular genetic tests , 2010, European Journal of Human Genetics.

[10]  David B. A. Epstein,et al.  Glandular Morphometrics for Objective Grading of Colorectal Adenocarcinoma Histology Images , 2017, Scientific Reports.

[11]  Aaron Carass,et al.  Why rankings of biomedical image analysis competitions should be interpreted with care , 2018, Nature Communications.

[12]  P Demoly,et al.  Hypersensitivity reactions to blood components: document issued by the allergy committee of the French medicines and healthcare products regulatory agency. , 2011, Journal of investigational allergology & clinical immunology.

[13]  Dmitrii Bychkov,et al.  Deep learning based tissue analysis predicts outcome in colorectal cancer , 2018, Scientific Reports.

[14]  Darren Treanor,et al.  Digital pathology access and usage in the UK: results from a national survey on behalf of the National Cancer Research Institute’s CM-Path initiative , 2018, Journal of Clinical Pathology.

[15]  Jon Griffin,et al.  Digital pathology in clinical use: where are we now and what is holding us back? , 2017, Histopathology.

[16]  Liron Pantanowitz,et al.  Validation of Digital Pathology for Primary Histopathological Diagnosis of Routine, Inflammatory Dermatopathology Cases , 2018, The American Journal of dermatopathology.